Acadia Pharmaceuticals Inc
ACAD· Nasdaq
ACADAcadia Pharmaceuticals Inc
Released May 4, 2018, before the open
10-Q filed May 4, 2018, 34 days after period end · 0001564590-18-010844
| Metric | Q1 2018 | Q1 2017 | Q1 2016 | Q1 2015 |
|---|---|---|---|---|
| Revenue | $48.87M | $15.29M | $4.00K | $4.00K |
| Net Income | -$54.30M | -$87.84M | -$49.76M | -$40.38M |
| EPS Diluted |
Acadia Pharmaceuticals Inc · CIK 1070494 · Engraved from SEC EDGAR
| -$0.44 |
| -$0.72 |
| -$0.45 |
| -$0.40 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
